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DOI: 10.1039/c1py00039jThis review aims to highlight the use of RAFT polymerization in the synthesis of polymer
bioconjugates. It covers two main bioconjugation strategies using the RAFT process: (i) post-
polymerization bioconjugations using pre-synthesized reactive polymers, and (ii) bioconjugations
via in situ polymerization using biomolecule-modified monomers or chain transfer agents.1 Introduction
1.1 Polymer bioconjugates
Polymer bioconjugates are formed by coupling synthetic or
biological polymer chains to biological molecules via covalent
bonds or bioaffinity interactions. Structural and functional
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This journal is ª The Royal Society of Chemistry 2011bioactivity, of biomolecules are usually altered upon coupling of
polymer chains.1–4 New features and functionality can also be
imparted to biomolecules by polymer conjugation, inducing
novel behaviors such as stimuli-responsive phase-separation,5,6
self-assembly,7,8 and patterning behaviors.9,10 Polymer bio-
conjugates find applications in different fields of (nano)biotech-
nology, biomedicine and pharmaceutical technologies. For
example, polyethylene glycol conjugates of several therapeutic
proteins have been used for treatment of diseases in humans.
Readers are referred to several excellent reviews on different
aspects of the biomolecule-polymer conjugates.11–25
Initial studies in the field of polymer bioconjugates
commenced in the mid 1970s. Reactive, linear/soluble polymers
were conjugated to enzymes to improve heat stability.26,27 In
1977, Davis and Abuchowski discovered the non-immunogenic
properties of polyethylene glycol (PEG) and developed a method
of attaching PEG to proteins (PEGylation) which prevented the
recognition of proteins by the immune system and slowed their
breakdown in the body.28 Following studies in later years
explored in more detail the conjugation of varying enzymes and
other proteins with stimuli-responsive polymers29–31 and other
water-soluble polymers.32,33 These early studies revealed the
potential of enyzme/protein-polymer conjugates in biosepara-
tions, bioreactions, diagnostics and drug delivery. The approval
of bovine adenosine deaminase – PEG conjugates by FDA in
1990 followed by intereferon-alpha, l-asparaginase and gran-
ulocyte colony-stimulating factor conjugates of PEG, to enter
the market as pharmaceuticals for human use, has further proved
the enormous potential of biomolecule-polymer conjugates in
biomedicine and pharmaceutical technologies.
In accord with the increasing utility of polymer bioconjugates
in different areas of biomedicine1,2,34,35 and (nano)biotech-
nology5,7–10,36 research has been driven into generating homoge-
neous and well-defined conjugates manifesting uniformity in
biohybrid properties and reproducible biological activity. The
properties of biomolecule-polymer conjugates usually need to be
tailored at molecular level to generate conjugates for a given
application. Molecular weight and its distribution, conjugation
site, molecular architecture, solubility, chemical and biological
functionality which appear to be the most important propertiesPolym. Chem., 2011, 2, 1463–1472 | 1463
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View Article Onlinefor bioconjugate designs, need to be well-controlled to establish
a solid correlation between the performance and bioconjugate
design.1,2,12,34Fig. 1 Reversible addition fragmentation chain transfer mechanism.1.2 Reversible addition fragmentation chain transfer (RAFT)
polymerization
Reversible addition fragmentation chain transfer (RAFT) poly-
merization, first reported in 1998 by Moad, Rizzardo and Thang
at CSIRO,37 is a living radical polymerization (LRP) technique,
a free radical polymerization technique which is not subject to
termination or transfer reactions and yields polymer chains that
are able to re-propogate by addition of free radicals and
monomers.
RAFT polymerization requires the use of thiocarbonylthio
moiety containing chain transfer agents (RAFT agents)
(Scheme 1). The RAFT mechanism and the appropriate RAFT
agent structures have been recently detailed in a number of
review articles.16,25,38,39 Briefly, during a RAFT process (Fig. 1),
the oligomeric radicals formed at the initiation stage of poly-
merization add to the highly reactive C]S bond of the RAFT
agents. Fragmentation of these radical intermediates results in
the formation of oligomeric RAFT agents and R group radicals.
The R-radicals should initiate the growth of polymer chains. The
growing polymeric radicals add to the polymeric RAFT agents
forming stabilized radical intermediates, following by the frag-
mentation to the polymeric RAFT agents and polymeric radi-
cals. At the end of polymerization, dormant polymeric
RAFT agents together with terminated polymeric radicals are
obtained.
RAFT polymerization benefits and suffers from all charac-
teristics of free radical polymerization process: It takes place
under facile reaction conditions. It is compatible with a wide
range of monomers, and tolerates varying functional chemical
groups. While RAFT polymerization is subject to undesirable
termination reactions, such reactions are greatly minimized with
respect to conventional free radical polymerization. This feature
provides control over the molecular weight and narrows the
molecular weight distribution of the polymer chains produced by
the RAFT technique. In addition, RAFT polymerization yields
polymers with defined chain end functionality as the alpha- and
omega-termini of living polymer chains are capped with R- and
Z- groups, respectively, of the RAFT agents, with the exception
of symmetric trithiocarbonate and Z-connected multi-RAFT
agents (Scheme 1).38,39 In cases where symmetrical trithiocar-
bonates or Z-connected multi-RAFT agents are used, theScheme 1 Schematic of the polymer synthesis by RAFT process using
a thiocarbonylthio or a symmetric trithiocarbonate RAFT agent.
1464 | Polym. Chem., 2011, 2, 1463–1472Z-group is located in the core and connects the arms of the
RAFT-synthesized polymer.40,41 It is also possible to create
various polymer architectures such as block and graft copoly-
mers, stars, and nanostructures using RAFT
polymerization.42,43,44–51
RAFT polymerization offers a highly versatile platform for
controlled synthesis and molecular engineering of polymer bio-
conjugates.13–16,25 The strength of the RAFT approach for
generation of polymer bioconjugates lies in its ability to control
the polymerization of a wide range of monomers in varying
solvents including water, at moderate temperatures, using only
chain transfer agents and common free radical initiators (without
the need for any additional polymerization component such as
metal catalysts and sacrificial initiators). Moreover, it enables the
synthesis of well-defined polymers with defined and spatially-
controlled chemical functionalities such as pendant-, mid-junc-
tion, alpha- and omega-end-group functionalities, suitable for
performing bioconjugations. In addition, the ability of RAFT
polymerization to synthesize designed architectures especially
block copolymers, gradient copolymers, stars and branched
structures potentially makes the generation of bioconjugates
with varying architectures possible, envisaging new or improved
applications of polymer bioconjugates.Fig. 2 Examples of RAFT agents and monomers used to generate
amine-reactive polymers.
This journal is ª The Royal Society of Chemistry 2011
Scheme 3 Bioconjugation strategies via in situ RAFT polymerization.
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View Article Online1.3 Scope of the review
This article aims to highlight the use of RAFT polymerization in
synthesis of polymer bioconjugates by reviewing some highlights
in the recent literature. It focuses only on the synthetic aspects of
bioconjugation strategies utilizing RAFT polymerization. It does
not intend to comprehensively summarize all of the work to date
in the field. Readers are also referred to several excellent reviews
covering comprehensively the use of living radical polymeriza-
tions in bioconjugations.13–16,25
Within this review, the term ‘‘biomolecule’’ has been used to
refer to the molecules originating from a living organism and the
synthetic analogs of such molecules. Thus, the conjugates of
synthetic peptides and nucleic acids have been included in the
review.
The review covers two main bioconjugation strategies:
(i) Post-polymerization bioconjugations (Scheme 2): Prepara-
tion of bioconjugates using pre-synthesized reactive polymers,
either functionalized by modification of their RAFT end-group
or synthesized directly by using functionalized RAFT agents, has
been reviewed. Bioconjugations have been classified according to
the reactivity of the polymers used.
(ii) Bioconjugations via in situ polymerization (Scheme 3):
Bioconjugations via in situ RAFT polymerization using
biomolecule-modified monomers or RAFT agents have been
reviewed.2 RAFT polymerization approach to polymer
bioconjugates
2.1 Post-polymerization bioconjugation strategy
In general, the conjugation of pre-synthesized, end-group func-
tionalized polymers to biomolecules has been the method ofScheme 2 Post-polymerization bioconjugation strategies using RAFT
technique.
This journal is ª The Royal Society of Chemistry 2011choice for preparation of bioconjugates using the RAFT poly-
merization approach. This method usually requires multiple
steps including the synthesis and purification of polymers,
conjugation to biomolecules and the purification of the final
conjugates, which significantly reduces the overall yield. Despite
this, the post-polymerization bioconjugation strategy has been
commonly used, mainly because of its compatibility with fragile
biomolecules. As it minimizes the number of steps involving the
biomolecules, the risk of altering the biomolecule’s conformation
and activity is reduced.
There are, in general, two common methods for generating
end-group functionalized RAFT-polymers for bioconjugations
(Scheme 2): (i) post-polymerization modification of the thio-
carbonylthio end-group of the synthesized polymers41,52,53 and
(ii) employing functionalized RAFT agents for direct synthesis of
polymers with a- and/or u- functionalities reactive towards
biomolecule’s functional groups.
With the former approach, u-thiol-terminated polymers have
been successfully generated by reaction of nucleophiles such as
amines,54–57 hydroxides55,58–60 and reducing agents such as bor-
onhydrides61–65 with the thiocarbonylthio group of the RAFT-
synthesized polymers. The thiol-functional polymers could be
further modified with thiol-reactive reagents, such as maleic
anhydride,66 for creating highly reactive sites for conjugation
with biomolecules. Alternatively, thiol-functional polymers can
be used directly for bioconjugations without any further modi-
fication.62,67–70 The removal of thiocarbonylthio group from the
bioconjugate structure may be an advantage of this approach as
the reactive thiocarbonylthio group may cause concentration-
dependent cytotoxicity if the bioconjugates are intended to be
used in living organisms.71,72 a- and/or u-functionality can be
also incorporated to a polymer chain during RAFT polymeri-
zation by using a RAFT agent with functionalized R- and/or
Z-groups, respectively. When designing R- and Z- groups,
amines, thiols, carboxylic acids and ketones/aldehydes, which are
the reactive groups of biological molecules, commonly used for
bioconjugations, have been considered.56,66,69,70,73–107 Bio-
conjugation strategies combining click reactions such as azide-
alkyne cycloadditions and thiol-ene additions with end-group
functionalized RAFT polymers have also attracted attention
because of high efficiency of such reactions (vide infra).
Among the post-polymerization bioconjugation strategies,
conjugation of relatively small molecular weight biomolecules
such as sugar residues, oligopeptides and vitamins such as biotinPolym. Chem., 2011, 2, 1463–1472 | 1465
Fig. 3 Thiazolidine-2-thione mid-functionalized RAFT agent and
schematic of umbrella-like (mid-functional) polymer attachment to
a protein.88
Fig. 4 RAFT polymerization of acetoxime acrylate in the presence of
a biotinylated chain transfer agent and subsequent treatment with
hydrazine to generate a-biotin,u-thiol poly(hydrazide acrylate).80
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View Article Onlineand folic acid, to the pendant-group functionalized polymers
have been also reported (Scheme 2).73,74,77,78,80,81
The examples of post-polymerization bioconjugations of
reactive RAFT polymers have been presented in the following
sections.
2.1.1 Conjugations using amine- or hydroxyl-reactive poly-
mers. The most traditional synthetic route for preparation of
polymer bioconjugates is to react amine or hydroxyl functional
groups of biomolecules with carboxylic acid-terminated poly-
mers. Conveniently, carboxylic acid is the most commonly used
functionality in RAFT-synthesized polymers. Several carboxyl-
functional RAFT agents (for example, 1 and 2, Fig. 2) have been
reported in the literature for direct synthesis of carboxyl func-
tional well-defined polymers.82,108–111
The bioconjugation reactions between carboxylic acid and amine
or hydroxyl groups usually require the use of carboxylic acid-acti-
vating agents to increase the conjugation yields. Thus, carboxylic
acid-terminated polymers synthesized by RAFT polymerization
have been activated using N-hydroxysuccinimide (NHS),112,113
pentafluorophenyl (PFP)82 or 2-mercaptothiozaline (3, Fig. 2).69
For example, the carboxyl end-group of semi-telechelic poly(N-
isopropylacrylamide) (pNIPAAm) synthesized by RAFT poly-
merization using 2-ethylsulfanylthiocarbonylsulfany1-2-methyl
propionic acid (2, Fig. 2) as a carboxylic acid-bearing RAFT agent
was modified with tetrafluorophenol to yield amine-reactive ester
groups for conjugation to amine groups of anti-streptavidin and
anti-Plasmodium falciparum histidine-rich protein 2 (PfHRP2)
antibodies. These conjugates were used to capture and detect
a model streptavidin antigen and subsequently to clinical ranges of
themalaria antigen Plasmodium falciparumhistidine-rich protein 2
(PfHRP2) from human plasma for a fluidic system.82
Following a more direct approach, RAFT agents can be first
functionalized with carboxylic acid active esters, and used for
conjugations with amine or hydroxyl groups.75,81,83,104 For
example, (2-oxopropyl)acrylate (5, Fig. 2) was efficiently poly-
merized in the presence of a pentafluorophenyl (PFP)-ester
functionalized trithiocarbonate RAFT agent (4, Fig. 2) to yield
polymers with low polydispersity index (PDI < 1.15) and pendant
ketone groups for the attachment of aminooxy glycans, as well as
alpha-terminal PFP ester and trithiocarbonate groups.81
Active ester approach has been also used for conjugation of
biomolecules to pendant groups of polymers.73,74,77,78 For
example, pentafluorophenyl acrylate (FP-A, 6, Fig. 2) was
polymerized in the presence of 3-(benzylsulfanylth-
iocarbonylsulfanyl)-propionic acid as a RAFT agent.78 Amine-
functional sugars, D-glucosamine and D-galactosamine, were
conjugated via nucleophilic addition to P(FP-A) in the presence
of triethylamine. The slow addition of reagents was noted to be
critical to ensure a full conversion of the activated ester.
A thiazolidine-2-thione mid-functionalized RAFT agent
(Fig. 3) was used for RAFT polymerization of N-(2-hydroxy-
propyl)methacrylamide (HPMA) to generate polymers with
mid-chain thiazolidine-2-thione functionality.88 These mid-
functionalized polymers yield branched biomolecule conjugates
with an ‘‘umbrella-like’’ polymeric structure (Fig. 3). The
branched polymer-lysozyme conjugates showed enhanced
stability and biological activity with respect to similar molecular
weight linear polyHPMA-lysozyme bioconjugates.881466 | Polym. Chem., 2011, 2, 1463–1472Aldehyde- and hydrazide functional polymers were also used
in conjugations with biomolecules through amine or hydroxyl
groups. For example, Godula and Bertozzi80 have reported
a relatively easier generic strategy for the synthesis of glycopol-
ymers with a broad scope of glycan structures. The proposed
strategy was based on the ligation of free reducing sugars to an
acryloyl hydrazide polymer with a biotin-end group (Fig. 4). A
variety of reducing glycans ranging in structure from simple
mono- and disaccharides to considerably more complex oligo-
saccharides were conjugated to the hydrazide pendant groups of
the polymer under acidic conditions in the presence of an aniline
catalyst. Glycopolymers were obtained in good to excellent yields
(37–85%) except sialyl N-acetyllactosamine and sialyl Lewis
glycans that were incorporated with 20 and 17% yield,
respectively.
Utilizing amine reactive polymers for preparation of protein-
or peptide-conjugates may result in the formation of heteroge-
nous conjugates due to the presence of a high number of amine
containing amino acid residues in proteins and peptides. One
route to site-selective conjugation of one polymer chain per
protein using amine-reactive polymers is to target only
N-terminus of proteins/peptides by precisely adjusting the pH of
the conjugation reaction to deprotonate only the a-amino group
of the terminal residue.2
2.1.2 Conjugations using thiol-reactive polymers. While the
amine or hydroxyl groups of proteins have been widely used for
conjugations, the conjugations via these groups often yield
heterogenous protein conjugates that show dispersity in the
number of polymer chains conjugated and the site of conjuga-
tion. This limits the consistency in the performance of the
conjugates. The thiol group is available in proteins to a lesser
extent in comparison with amine and hydroxyl groups. There are
also proteins, such as streptavidin, that do not possess any non-
oxidized thiol residues. Thus inserting a unique cysteine (thiol)
residue into such a protein structure via protein engineering
techniques6 can create a perfect site for conjugation of a singleThis journal is ª The Royal Society of Chemistry 2011
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View Article Onlinepolymer chain. In addition to proteins, the thiol group can also
provide a unique conjugation site for nucleic acid and sugar
based biomolecules.114,115 Considering this, allyl, maleimide,
vinylsulfone and pyridyldisulfide-functionalities have been
widely used in RAFT-polymers either as pendant- or end-groups
reactive towards thiol (detailed below).
RAFT agents bearing a-allyl or a,u-bis-allyl groups have been
described.116,117 Allyl-pendant functionalized monomers have
also been polymerized by RAFT process.118 Allyl-functionality is
of particular interest as it can be exploited for modification via
orthogonal thiol-ene reactions.118–121 Maleimide-terminated or
-pendant functionalized polymers have also been synthesized
using theRAFTprocess.86,91,92,98,122Poly(N-isopropylacrylamide)
(PNIPAM) prepared by RAFT polymerization was aminolyzed
to yield thiol-terminated chains that were subsequently reacted
with excess 1,8-bis-maleimidodiethyleneglycol. The resulting
maleimide-terminated polymer was reacted with BSA and oval-
bumin to yield heterotelecehlic polymer protein conjugates by two
consecutive Michael addition thiol-ene reactions.98 Vinyl sulfone
is another group which is highly reactive toward thiols. The
reduction of the RAFT dithiobenzoate group and simultaneous
trapping with divinyl sulfone to produce Michael acceptor poly-
mers was recently reported.123 The semitelechelic vinyl sulfone
polymers were conjugated via a highly efficient reaction to the free
cysteine residue of bovine serum albumin (BSA). Importantly,
after polymer attachment, the activity of the BSA was 92% of the
unmodified biomolecule.124
Pyridyl disulfide (PDS) is an effective active group towards the
selective-exchange reaction with thiols under mild conditions.125
The formation of reversible disulfide linkages upon thiol-PDS
reaction makes pyridyl disulfide a useful group for preparation of
reversible bioconjugates.126–128 The combination of PDS group
with RAFT polymerization was first reported with a PDS-
functionalized trithiocarbonate RAFT agent.129 Given its
versatility, the PDS group has been widely used in RAFT-
mediated bioconjugations.40,56,67–70,93,94,105,106,114,127 Various PDS
functionalized RAFT-agents including a mid-chain PDS func-
tional chain transfer agent87 have been reported.40,89,114,130–134 For
example, Duvall et al.90 synthesized a new PDS functional RAFT
agent, trithiocarbonic acid 1-cyano-1-methyl-3-[2-(pyridin-2-
yldisulfanyl)ethylcarbamoyl]propyl ester ethyl ester to generate
PDS-functionalized block copolymers. The PDS functionality of
the block copolymer provided a reversible peptide conjugation
site. A cell-internalized proapoptotic peptide was conjugated via
a disulfide-thiol exchange reaction with a conjugation yield of
75%. In another study,114well-defined a-PDS functionalized poly
(oligoethylene glycol acrylate)s that were synthesized using
a PDS-modified trithiocarbonate RAFT agent was conjugated to
50-thiol-modified small interfering RNA (siRNA) to increase the
nuclease stability of siRNA.135
It is also possible to incorporate u-PDS functionality by in situ
aminolysis of the thiocarbonylthio end group of RAFT-poly-
mers in the presence of 2,20-dithiodipyridine.56,67,68–70,136 This
approach produces PDS-functional polymers with high yields
(close to 90%) without accompanying side-reactions such as
disulfide or thiolactone formation. The ‘‘in situ aminolysis’’
approach can also be performed in the presence of ene-bearing
molecules to generate polymers with different u-functionality
with high yields.68,136This journal is ª The Royal Society of Chemistry 2011Pyridyldisulfide ethylmethacrylate was (co)polymerized via
RAFTprocess using adithiobenzoate chain transfer agent to yield
well-defined (co)polymers with PDS pendant groups.43,93,106 The
PDSpendant groupswere utilized to conjugate anticancer drugs95
and fluorescent probes.105 Following a different approach, a
well-defined N-(2-hydroxypropyl)methacrylamide-s-N-(3-ami-
nopropyl)methacrylamide (HPMA-S-APMA) copolymer,
synthesized via RAFT polymerization, was modified with
N-succinimidyl 3-(2-pyridyldithio)-propionate (SPDP) to convert
to the pendant amine groups to PDS functionality. 50-sense strand
thiolated RNAs were then coupled to the polymer through
a disulfide exchange with pendant PDS moieties, giving a conju-
gation yield of 89 4%.84Here it is worth noting that the authors
used single-strandRNA for conjugations to obtain relatively high
conjugation yields. The complementary strand RNAs were then
base-paired with RNA-polymer conjugates. The conjugation of
macromolecules to pendant functionalized polymers usually
results in low conjugation yields due to steric hindrance effects.
2.1.3 Conjugations using carboxylic acid-reactive polymers.
Hydroxyl- and amine-functionalized polymers have been limit-
edly used by RAFT-mediated bioconjugation strategies. RAFT
agents bearing hydroxyl group and RAFT polymerization of
hydroxyl monomers such as hydroxyethylmethacrylate (HEMA)
have been studied.137,138
Except a few recent studies,84,95,100 the primary and secondary
amine functionalities, have not been directly accessible viaRAFT
polymerization mainly due to the degradation of RAFT agents
during polymerization. This limitation has been overcome by
several indirect routes including the protection of amine groups
by tert-butyloxycarbonate (t-BOC) during polymerization.107
Recently, following a direct approach, Deng et al.96 synthe-
sized diblock copolymers with 2-lactobionamidoethyl meth-
acrylamide and 3-aminopropyl methacrylamide hydrochloride
blocks via chain extension RAFT polymerization in water using
azobis(4-cyanovaleric acid) (ACVA) as an initiator and 4-cya-
nopentanoic acid dithiobenzoate as a RAFT agent. The primary
amine pendant groups of the copolymer were modified with
biotinyl-N-hydroxysuccinimide ester to prepare glyco-
nanoparticles for biomolecular recognition processes against
avidin and a lectin. Similarly, Henry et al.97 used N-(2-amino-
ethyl)maleimide trifluoroacetate to introduce a single primary
amine group to the omega-terminus of poly(dimethylaminoethyl
methacrylate) and poly(N-isopropyl acrylamide) and also to
a specialized block copolymer. Addition of a single maleimide
monomer to the polymer allowed the functional group to be
located at the junction of two blocks. The polymers were func-
tionalized with an amine-reactive fluorescent dye or folic acid
with a conjugation efficiency of 86 and 94%, respectively. It was
noted that the triflate salt of N-(2-aminoethyl)maleimide (AM)
prevented reduction of the RAFT agent during polymerization.
In studies by York et al.84,85 and Alidedeoglu et al.100 homo-
and copolymers of a primary amine containing monomer, N-(3-
aminopropyl)methacrylamide (APMA) were prepared in an
aqueous acetic buffer (pH 5.2 to prevent degradation of dithio-
benzoate functionality) using 4-cyanopentanoic acid dithio-
benzoate as a RAFT agent. APMA provided amine
functionality, allowing conjugation of cell-targeting folate
derivatives and o-glucuronic acid.Polym. Chem., 2011, 2, 1463–1472 | 1467
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View Article OnlineThese recent studies focussing on the synthesis of amine-
functionalized RAFT polymers and their use for bioconjugations
are significant as the degradation of RAFT agents in the presence
of amines has been one of the main barriers to the use of RAFT
technique for bioconjugations. Especially since carboxylic acid-
amine reactions have been among the most widely used chem-
istries for bioconjugations, and various amine-reactive reagents
(such as fluorescent probes) and biomolecules (such as proteins
and peptides containing acidic residues) are widely available, the
ability to synthesize amine-functionalized polymers via the
RAFT technique clearly makes the technique more practical for
bioconjugation applications.
2.1.4 Conjugations using click reactions. Click reactions such
as copper-catalyzed azide-alkyne cycloadditions, thiol-ene addi-
tions andO-hydroxylamine-aldehyde/ketone reactions have been
integrated with the field of polymer-bioconjugates as they are
fast, highly efficient and selective reactions that can be conducted
under relatively mild conditions.139,140 Particularly, reactions that
do not require metal catalysts and extensive modifications on the
biomolecule structure are highly promising to improve the
homogeneity of biomolecule–polymer conjugates.
A copper-catalyzed azide-alkyne click reaction was used to
couple a self-assembling, azide functionalized, cyclic octapeptide
with an alkyne functionalized RAFT polymer.102 Following the
samemethodology, immunogenic peptides (a tetrapeptide and an
eicosapeptide) from the cancer-associated glycoprotein MUC1
were conjugated with poly(NIPAAm).103 In this case, 3-(trime-
thylsilyl)prop-2-ynyl-2-(butylthiocarbonothioylthio) propanoate
was used as a functional RAFT agent to directly synthesize poly
(NIPAAm) with a-trimethylsilyl protected alkyne group.
While copper catalyzed click reactions are highly efficient, the
use of metal catalyst may cause concerns for conjugations of
proteins, peptides and DNA/RNA which contain moieties
complexing with metals.141 In this context, thiol-ene additions
present a better alternative path to bioconjugates.99,104,137 The
thiocarbonylthio functionality of RAFT polymers has been
in situ aminolyzed to thiol in the presence of ene-containing
biomolecules such as maleimide-biotin and sugar (meth)acrylates
which have led to highly efficient bioconjugations.56,67,69,79 In situ
aminolysis approach avoids the formation of disulfide interchain
couplings, usually observed with two-step aminolysis and
conjugation strategy. It is worth noting that the use of tri-n-butyl
phosphine as a reductant in the two-step strategy can also avoid
the formation of disulfides.142
Aminooxy functionalized polymers can be conjugated to
ketone or aldehyde engineered biomolecules via a click mecha-
nism. A well-defined PNIPAAm (Mn ¼ 4200 Da by NMR;
PDI ¼ 1.14 by GPC) was synthesized in the presence of a Boc-
protected aminooxy trithiocarbonate chain transfer agent.100
Following the removal of the Boc group, the polymer’s ami-
nooxy terminal was conjugated with N0-levulinyllysine-modified
BSA in solution or aldehyde-modified heparin on a gold
surface, forming oxime bonds. While the conjugations via this
strategy are highly chemoselective and occur without side
reactions with functional groups on proteins, they require
proteins engineered with levulinic acid or aminooxyacetic acid143
to create ketone or aldehyde functionality on the protein
surface.1468 | Polym. Chem., 2011, 2, 1463–14722.1.5 Conjugations using non-covalent interactions. Bio-
affinity interactions between ligand-functionalized polymers and
proteins have also been used. The most widely used bioaffinity
interaction in RAFT-mediated bioconjugations is the interaction
between (strept)avidin and biotin, which is one of the strongest
non-covalent interactions.92,93,108,135,144 For example, in a recent
study,106 a-biotin PEG-b-poly(pyridyldisulfide ethyl-
methacrylate) block copolymers were synthesized via RAFT
polymerization and used to form disulfide crosslinked micelles
with biotin-functionalized surface. The affinity interaction of
streptavidin with the surface biotins led to the formation of
streptavidin-linked micelle aggregates with tunable dimensions.
Another example of protein–ligand interactions in RAFT-
mediated bioconjugations was demonstrated by Chang et al.90
Reduced glutathione-modified PNIPAAm, synthezied using
a RAFT agent modified with pyridyl disulfide and subsequently
conjugated with glutathione via thiol-disulfide exchange reac-
tion, was used to capture glutathione-S-transferase (GST) via
affinity binding. The polymer demonstrated specificity only for
GST among other proteins such as BSA and lysozyme.
In an interesting study, Tominey et al.145 proposed the devel-
opment of RAFT-synthesized polymeric artificial receptors for
proteins. A number of functionalized monomers were copoly-
merized using a water-soluble symmetric trithiocarbonate RAFT
agent. Cytochrome C, hemoglobin, BSA, histone, lysozyme,
proteinase K were tested for selective binding to RAFT poly-
mers. The pair with the highest affinity was found to be
a bisphosphonate-containing RAFT polymer and histidine-rich
histone (Kd ¼ 16 nM). While RAFT polymerization appears to
be the most amenable technique for the generation of biomimetic
structures for such precise applications, the polymerization
conditions need to be optimized very carefully to minimize the
polydispersity of the polymers produced, as polydispersity, in
this case, is extremely critical for the binding events due to the
different affinities and binding stoichiometries of polymers of
different chain length.
Other than the (strept)avidin–biotin pair, there are only a few
other protein–ligand pairs, as detailed above, that have been
investigated in RAFT-mediated bioconjugation strategies.
Cofactor reconstitutions, metal-protein ligand coordinations,
dye-affinity interactions remain to be investigated for bio-
conjugation of RAFT polymers using non-covalent interactions.2.2 Bioconjugations via in situ polymerization strategy
An alternative route to well-defined bioconjugates, first proposed
by Maynard and co-workers for ATRP-mediated bio-
conjugations,127,128 is the in situ generation of conjugates by
polymerization of biomolecule-modified RAFT agents or
biomolecule-modified monomers. The in situ polymerization
strategy has a number of advantages over the post-polymeriza-
tion conjugation strategy: (i) the overall number of synthetic
steps are reduced, (ii) it is easier to control the number and
conjugation site of the attached polymer, (iii) purification steps
are simplified, (iv) the conjugation yields are higher, (v) better-
defined bioconjugates with greatly reduced heterogeneity are
obtained. Together with these advantages, an important issue
with the in situ polymerization approach is that although the
number of overall synthetic steps is less, there are more stepsThis journal is ª The Royal Society of Chemistry 2011
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View Article Onlineinvolving the biomolecule in comparison with the post-poly-
merization conjugation strategy. Thus the treatment conditions
(for example: solvent, temperature, radical concentration, pres-
ence of salts) during the steps involving fragile biomolecules such
as proteins, large peptides and DNA/RNA, need to be carefully
optimized to preserve the conformation and activity of the
biomolecule. The same concern is also valid for the preservation
of thiocarbonylthio structure in the presence of certain biomol-
ecules such as amine deprotected peptides.
The advantages of RAFT polymerization, important for bio-
conjugations, over the other living radical polymerization tech-
niques can be listed as follow: The variety of the monomers that
can be polymerized by RAFT is large. The use of metal catalysts
and additional agents such as sacrifical initiators is not needed.
The synthesis of well-defined biomolecule-polymer conjugates in
easily detectable quantities using only RAFT agent-modified
biomolecules and common free radical initiators is possible.
Peptide,146–149 protein134,150,151 or DNA-modified152 RAFT
agents have been used for in situ bioconjugate formation via
RAFT polymerization. The in situ RAFT polymerization
approach using peptide-RAFT agents has been performed only
with simple and protected peptides, mainly due to the degrada-
tion problem of the RAFT agents in the presence of deprotected
peptides. However, recently, a few studies reported the successful
RAFT polymerization of monomers functionalized with depro-
tected, longer chain peptides (vide infra).153,154
The synthesis of protein-macroRAFT agents (Fig. 5) was
performed using a selective thiol-disulfide exchange reaction of
Z-group pyridyl disulfide-functionalized RAFT agents with the
single non-oxidized cysteine (cys-34) residue of BSA.134,151 Using
BSA-RAFT agents, BSA-PNIPAAm, BSA-POEG-A, BSA-
PHEA conjugates were in situ generated at ambient temperatures
using azo-initiators or g-radiation. De et al.150 used the R-
approach for modification of the RAFT agent with BSA (Fig. 5)
via thiol-maleimide addition reaction. Disulfide bonds present in
native BSAwere reduced to increase the number of free thiols per
protein, providing multiple attachment sites. The resultant BSA-
macroRAFT agent was used to control the polymerization of
NIPAAm at room temperature using similar conditions to those
reported previously.151 The R-group-protein-modified RAFT
agent design reduces steric hindrance during polymerization
while the Z-group- modified RAFT agent design is affected by
steric hindrance and may reduce the polymerization efficiency.
Also, conjugating via Z-approach results in hydrolyzable
conjugates, due to the presence of the labile C–S bond betweenFig. 5 Bovine serum albumin (BSA)-macro RAFT agents.134,150,151
This journal is ª The Royal Society of Chemistry 2011the biomolecule and the polymer chain, which might be favor-
able for certain applications.
Peng and Lin152 reported the synthesis of surface-anchored
DNA-RAFT agent to prepare a DNA-b-polymer-grafted gold
surface. An N-hydroxysuccinimide activated trithiocarbonate
RAFT agent (2-(1-carboxy-1-methylethylsulfanylth-
iocarbonylsulfanyl)-2-methyl propionic acid) was attached to
50-amino, 30-disulfide-functionalized single stranded DNA
through its 50-amino end. The attachment of the DNA-RAFT
agent to the gold surface was performed after the reduction of the
30-disulfide group of DNA by DTT addition. Importantly, this
step did not degrade the RAFT agent structure or caused any
unwanted interaction between the RAFT agent and the gold
surface. It was previously shown131 that a PDS-functionalized
trithiocarbonate RAFT agent can bind to gold surface via
disulfide reduction and gold-thiol binding preserving the
trithiocarbonate group intact. The OEG-MA monomer was
polymerized from the surface-grafted DNA-RAFT agent under
unconventional polymerization conditions (using AIBN as an
initiator in water at 30 C for 5 h).152 Free radical polymerization
in solution, as the side reaction, was found to increase with raised
temperature, consequently no polymer growth was observed on
the surface at higher polymerization temperatures. An important
observation was that the grafting kinetics in the presence of
DNA molecules, even at a relatively low grafting density, was
faster, compared to the surface modified with a small molecule
coupled-RAFT agent.
RAFT polymerization of biomolecule-modified monomers
has also been investigated to prepare a number of biomolecule-
polymer pendant conjugates, usually using saccharide resi-
dues82,96,97,155–157 and peptides153,154,158 as a biomolecule. In
a study aimed to develop a gene carrier,154 methacrylamide
monomers of a DNA condensing peptide (K-12) and an endo-
somal escape peptide (K6H5) were RAFT-copolymerized with
N-(2-hydroxypropyl(methacrylamide) (HPMA) under aqueous
conditions using ethyl cyanovaleric trithiocarbonate as a RAFT
agent and VA-044 as an initiator in acetate buffer (pH 5.1) at
44 C for 48 h. An important note is that the peptides used in
polymerizations were deprotected. An acetic acid buffer at pH
5.1 with a molar strength of 1Mwas used to ensure that 3-amines
of L-lysine were fully protonated, thereby protecting the trithio-
carbonate from nucleophilic attack. Statistical copolymers with
highly controlled molecular weight and composition were
obtained. The copolymers efficiently condensed DNA into small
particles which were stable even in a physiologically-relevant salt
solution. With increasing peptide content, the peptide-based
polymers demonstrated gene delivery efficiencies to HeLa cells
that were comparable to branched polyethylenimine.Conclusions
The strength of the RAFT approach for generation of polymer
bioconjugates lies in its ability to control the polymerization of
a wide range of monomers in varying solvents including water, at
moderate temperatures, using only chain transfer agents and
common free radical initiators. The simple set up of RAFT
polymerization and the commercial availability of RAFT agents
make the RAFT technique accessible to researchers from
different fields including biotechnology and biomedicine andPolym. Chem., 2011, 2, 1463–1472 | 1469
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View Article Onlinemost amenable to the generation of bioconjugates with improved
properties. Accordingly, RAFT-mediated strategies have been
increasingly used to prepare biomolecule-polymer conjugates
with well-defined composition, size, molecular architecture and
conjugation site. Especially with the combination of orthogonal
chemistries with RAFT polymerization, access to well-defined
conjugates with designed architectures at high yields has been
possible. These synthetic abilities envisage new or improved
applications of biomolecule-polymer conjugates. The impact of
the RAFT technique on preparation of bioconjugates should be
significant, particularly for drug delivery, diagnostics/biosensors
and biopurifications where the physicochemical features of bio-
conjugates need to be tuned very precisely to have desirable and
consistent performance.References
1 W. P. Gao, W. G. Liu, T. Christensen, Z. M. R. Zalutsky and
A. Chilkoti, Proc. Natl. Acad. Sci. U. S. A., 2010, 107, 16432.
2 W. P. Gao, W. G. Liu, J. A. Mackay, M. R. Zalutsky, E. J. Toone
and A. Chilkoti, Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 15231.
3 J. M. Harris, N. E. Martin and M. Modi, Clin. Pharmacokinet.,
2001, 40, 539.
4 S. M. Ryan, X. Wang, G. Mantovani, C. T. Sayers,
D. M. Haddleton and D. J. Brayden, J. Controlled Release, 2009,
135, 51.
5 Z. L. Ding, R. B. Fong, C. J. Long, P. S. Stayton and A. S. Hoffman,
Nature, 2001, 411, 59.
6 P. S. Stayton, T. Shimoboji, C. Long, A. Chilkoti, G. H. Chen,
J. M. Harris and A. S. Hoffman, Nature, 1995, 378, 472.
7 S. F. M. Van Dongen,M. Nallani, J. Cornelissen, R. J. M. Nolte and
J. C. M. Van Hest, Chem.–Eur. J., 2009, 15, 1107.
8 B. Le Droumaguet and K. Velonia,Angew. Chem., Int. Ed., 2008, 47,
6263.
9 K. L. Christman, E. Schopf, R. M. Broyer, R. C. Li, Y. Chen and
H. D. Maynard, J. Am. Chem. Soc., 2009, 131, 521.
10 K. L. Christman, R. M. Broyer, Z. P. Tolstyka and H. D. Maynard,
J. Mater. Chem., 2007, 17, 2021.
11 G. Pasut andF.M.Veronese,Adv.DrugDeliveryRev., 2009, 61, 1177.
12 A. Monzur and S. Brocchini, Adv. Drug Delivery Rev., 2006, 58,
1671.
13 G. N. Grover andH. D.Maynard,Curr. Opin. Chem. Biol., 2010, 14,
818.
14 M. A. Gauthier and H. A. Klok, Polym. Chem., 2010, 1, 1352–1373.
15 K. Velonia, Polym. Chem., 2010, 1, 944.
16 B. Le Droumaguet and J. Nicolas, Polym. Chem., 2010, 1, 563.
17 A. K. Shakya, H. Sami, A. Srivastava and A. Kumar, Prog. Polym.
Sci., 2010, 35, 459.
18 L. A. Canalle, D.W. P.M. Lowik and J. C.M. VanHest,Chem. Soc.
Rev., 2010, 39, 329.
19 F. H. Meng, W. E. Hennink and Z. Zhong, Biomaterials, 2009, 30,
218.
20 J. H. Jeong, H. Mok, Y. K. Oh and T. G. Park, Bioconjugate Chem.,
2009, 20, 5.
21 J. F. Lutz and Z. Zarafshani, Adv. Drug Delivery Rev., 2008, 60, 958.
22 J. F. Lutz and H. G. Borner, Prog. Polym. Sci., 2008, 33, 1.
23 J. Nicolas, G. Mantovani and D. M. Haddleton, Macromol. Rapid
Commun., 2007, 28, 1083.
24 A. S. Hoffman and P. Stayton, Prog. Polym. Sci., 2007, 32, 922.
25 C. Boyer, V. Bulmus, T. P. Davis, V. Ladmiral, J. Liu and
S. B. Perrier, Chem. Rev., 2009, 109, 5402.
26 R. Epton, G. Marr and G. J. Morgan, Polymer, 1977, 18, 319.
27 R. Epton, M. E. Hobson and G. Marr, Polymer, 1977, 18, 1203.
28 A. Abuchowski, T. Vanes, N. C. Palczuk and F. F. Davis, J. Biol.
Chem., 1977, 252, 3578.
29 G. H. Chen and A. S. Hoffman, Bioconjugate Chem., 1993, 4, 509.
30 Z. L. Ding, G. H. Chen and A. S. Hoffman, Bioconjugate Chem.,
1996, 7, 121.
31 T. Shimoboji, Z. L. Ding, P. S. Stayton and A. S. Hoffman,
Bioconjugate Chem., 2002, 13, 915.1470 | Polym. Chem., 2011, 2, 1463–147232 W. N. E. Van Dijk-Wolthuis, P. van de Wetering, W. L. J. Hinrichs,
L. J. F. Hofmeyer, R. M. J. Liskamp, D. J. A. Crommelin and
W. E. Hennink, Bioconjugate Chem., 1999, 10, 687.
33 F. M. Veronese, Biomaterials, 2001, 22, 405.
34 S. Shaunak, A. Godwin, J.-W. Choi, S. Balan, E. Pedone,
D. Vijayarangam, S. Heidelberger, I. Teo, M. Zloh and
S. Brocchini, Nat. Chem. Biol., 2006, 2, 161, 219, 221.
35 C. Fleming, A. Maldjian, D. Da Costa, A. K. Rullay,
D. M. Haddleton, J. St. John, P. Penny, R. C. Noble,
N. R. Cameron and B. G. Davis, Nat. Chem. Biol., 2005, 1, 270.
36 A. J.Dirks,R. J.M.Nolte and J.Cornelissen,Adv.Mater., 2008, 20, 3953.
37 J. Chiefari, Y. K. Chong, F. Ercole, J. Krstina, J. Jeffery, T. P. T. Le,
R. T. A. Mayadunne, G. F. Meijs, C. L. Moad, G. Moad,
E. Rizzardo and S. H. Thang, Macromolecules, 1998, 31, 5559.
38 G. Moad, E. Rizzardo and S. H. Thang, Aust. J. Chem., 2009, 62,
1402.
39 G. Moad, M. Chen, M. Haussler, A. Postma, E. Rizzardo and
S. H. Thang, Polym. Chem., 2011, 2, 492.
40 J. Q. Liu, H. Y. Liu, V. Bulmus, L. Tao, C. Boyer and T. P. Davis,
J. Polym. Sci., Part A: Polym. Chem., 2010, 48, 1399.
41 G. Moad, E. Rizzardo and S. H. Thang, Polym. Int., 2011, 60, 9.
42 C. Boyer, M. H. Stenzel and T. P. Davis, J. Polym. Sci., Part A:
Polym. Chem., 2011, 49, 551.
43 L. J. Wong, S. Sevimli, H. M. Zareie, T. P. Davis and V. Bulmus,
Macromolecules, 2010, 43, 5365.
44 S. Kirkland-York, K. Gallow, J. Ray, Y.-L. Loo and C. Mccormick,
Soft Matter, 2009, 5, 2179.
45 M. G. Kellum, A. E. Smith, S. K. York and C. L. Mccormick,
Macromolecules, 2010, 43, 7033.
46 A. E. Smith, X. W. Xu, D. A. Savin and C. L. Mccormick, Polym.
Chem., 2010, 1, 628.
47 A. E. Smith, X. W. Xu, S. E. Kirkland-York, D. A. Savin and
C. L. Mccormick, Macromolecules, 2010, 43, 1210.
48 E. Schopf, R. Broyer, L. Tao, Y. Chen and H. D. Maynard, Chem.
Commun., 2009, (32), 4818.
49 J. Q. Liu, L. Tao, W. R. Yang, D. Li, C. Boyer, R. Wuhrer, F. Braet
and T. P. Davis, Langmuir, 2010, 26, 10068.
50 M. Glassner, J. P. Blinco and C. Barner-Kowollik, Polym. Chem.,
2011, 2, 83.
51 W. M. Wan and C. Y. Pan, Polym. Chem., 2010, 1, 1475.
52 H. Willcock and R. K. O’reilly, Polym. Chem., 2010, 1, 149.
53 C. Barner-Kowollik, Handbook of RAFT Polymerization, 2008,
Wiley-VCH, Weinheim.
54 X. P. Qiu and F. M. Winnik, Macromolecules, 2007, 40, 872.
55 B. Yu, J. W. Can, C. E. Hoyle and A. B. Lowe, J. Polym. Sci., Part
A: Polym. Chem., 2009, 47, 3544.
56 C. Boyer, V. Bulmus and T. P. Davis, Macromol. Rapid Commun.,
2009, 30, 493.
57 W. Shen, Q. Qiu, Y.Wang,M.Miao, B. Li, T. Zhang, A. N. Cao and
Z. S. An, Macromol. Rapid Commun., 2010, 31, 1444.
58 S. Harrisson, Macromolecules, 2009, 42, 897.
59 M. I. Gibson, E. Frohlich and H.-A. Klok, J. Polym. Sci., Part A:
Polym. Chem., 2009, 46, 4332.
60 S. Kulkarni, C. Schilli, B. Grin, A. H. E. Muller, A. S. Hoffman and
P. S. Stayton, Biomacromolecules, 2006, 7, 2736.
61 A. B. Lowe, B. S. Sumerlin, M. S. Donovan and C. L. McCormick,
J. Am. Chem. Soc., 2002, 124, 11562.
62 A. N. Zelikin, G. K. Such, A. Postma and F. Caruso,
Biomacromolecules, 2007, 8, 2950.
63 B. S. Sumerlin, A. B. Lowe, P. A. Stroud, P. Zhang, M. W. Urban
and C. L. McCormick, Langmuir, 2003, 19, 5559.
64 A. S. Goldmann, A. Walther, L. Nebhani, R. Joso, D. Ernst,
K. Loos, C. Barner-Kowollik, L. Barner and A. H. E. Muller,
Macromolecules, 2009, 42, 3707.
65 J. M. Spruell, B. A. Levy, A. Sutherland, W. R. Dichtel, J. Y. Cheng,
J. F. Stoddart and A. Nelson, J. Polym. Sci., Part A: Polym. Chem.,
2009, 47, 346.
66 B. Sasso, M. Dobinson, P. Hodge and T. Wear, Macromolecules,
2010, 43, 7453.
67 C. Boyer, J. Liu, V. Bulmus and T. P. Davis, Aust. J. Chem., 2009,
62, 830.
68 C. Boyer, A. Granville, T. P. Davis and V. Bulmus, J. Polym. Sci.,
Part A: Polym. Chem., 2009, 47, 3773.
69 J. Xu, C. Boyer, V. Bulmus and T. P. Davis, J. Polym. Sci., Part A:
Polym. Chem., 2009, 47, 4302.This journal is ª The Royal Society of Chemistry 2011
Pu
bl
ish
ed
 o
n 
31
 M
ay
 2
01
1.
 D
ow
nl
oa
de
d 
on
 1
0/
03
/2
01
7 
10
:5
3:
07
. 
View Article Online70 J. Xu, L. Tao, J. Liu, V. Bulmus and T. P. Davis, Macromolecules,
2009, 42, 6893.
71 D. Pissuwan, C. Boyer, K. Gunasekaran, T. P. Davis and V. Bulmus,
Biomacromolecules, 2010, 11, 412.
72 C.W. Chang, E. Bays, L. Tao, S. N. S. Alconcel and H. D.Maynard,
Chem. Commun., 2009, (24), 3580.
73 F. D. Jochum, P. J. Roth, D. Kessler and P. Theato,
Biomacromolecules, 2010, 11, 2432.
74 K. T. Wiss, D. Kessler, T. J. Wendorff and P. Theato, Macromol.
Chem. Phys., 2009, 210, 1201.
75 K. T. Wiss, O. D. Krishna, P. J. Roth, K. L. Kiick and P. Theato,
Macromolecules, 2009, 42, 3860.
76 J. Xu, L. Tao, C. Boyer, A. B. Lowe and T. P. Davis,
Macromolecules, 2011, 44, 299.
77 M. Barz, F. Canal, K. Koynov, R. Zentel and M. J. Vicent,
Biomacromolecules, 2010, 11, 2274.
78 C. Boyer and T. P. Davis, Chem. Commun., 2009, (40), 6029.
79 H. T. T. Duong, T. L. U. Nguyen and M. H. Stenzel, Polym. Chem.,
2010, 1, 171.
80 K. Godula and C. R. Bertozzi, J. Am. Chem. Soc., 2010, 132, 9963.
81 K. Godula, D. Rabuka, K. T. Nam and C. R. Bertozzi, Angew.
Chem., Int. Ed., 2009, 48, 4973.
82 A. L. Golden, C. F. Battrell, S. Pennell, A. S. Hoffman, J. J. Lai and
P. S. Stayton, Bioconjugate Chem., 2010, 21, 1820.
83 P. J. Roth, F. D. Jochum, R. Zentel and P. Theato,
Biomacromolecules, 2010, 11, 238.
84 A. W. York, F. Q. Huang and C. L. McCormick,
Biomacromolecules, 2010, 11, 505.
85 A.W. York, Y. L. Zhang, A. C. Holley, Y. L. Guo, F. Q. Huang and
C. L. McCormick, Biomacromolecules, 2009, 10, 936.
86 L. Tao, C. S. Kaddis, R. R. O. Loo, G. N. Grover, J. A. Loo and
H. D. Maynard, Macromolecules, 2009, 42, 8028.
87 L. Tao, J. Q. Liu and T. P. Davis, Biomacromolecules, 2009, 10,
2847.
88 L. Tao, J. T. Xu, D. Cell and T. P. Davis,Macromolecules, 2010, 43,
3721.
89 C.W. Chang andH. D.Maynard,Macromol. Rapid Commun., 2010,
31, 1691.
90 C. L. Duvall, A. J. Convertine, D. S. W. Benoit, A. S. Hoffman and
P. S. Stayton, Mol. Pharmaceutics, 2010, 7, 468.
91 K. L. Heredia, G. N. Grover, L. Tao and H. D. Maynard,
Macromolecules, 2009, 42, 2360.
92 K. L. Heredia, L. Tao, G. N. Grover and H. D. Maynard, Polym.
Chem., 2010, 1, 168.
93 L. J. Wong, C. Boyer, Z. Jia, M. H. Zareie, T. P. Davis and
V. Bulmus, Biomacromolecules, 2008, 9, 1934.
94 L. J. Wong, M. Kavallaris and V. Bulmus, Polym. Chem., 2011, 2,
385.
95 Z. C. Deng, M. Ahmed and R. Narain, J. Polym. Sci., Part A:
Polym. Chem., 2009, 47, 614.
96 Z. C. Deng, S. Q. Li, X. Z. Jiang and R. Narain, Macromolecules,
2009, 42, 6393.
97 S. M. Henry, A. J. Convertine, D. S. W. Benoit, A. S. Hoffman and
P. S. Stayton, Bioconjugate Chem., 2009, 20, 1122.
98 M. Li, P. De, H. M. Li and B. S. Sumerlin, Polym. Chem., 2010, 1,
854.
99 V. Vazquez-Dorbatt, Z. P. Tolstyka and H. D. Maynard,
Macromolecules, 2009, 42, 7650.
100 A. H. Alidedeoglu, A. W. York, D. A. Rosado, C. L. McCormick
and S. E. Morgan, J. Polym. Sci., Part A: Polym. Chem., 2010, 48,
3052.
101 R. Chapman, K. A. Jolliffe and S. Perrier, Aust. J. Chem., 2010, 63,
1169.
102 H. Kakwere, H. C. K. Y. Chun, K. A. Jolliffe, R. J. Payne and
S. Perrier, Chem. Commun., 2010, 46, 2188.
103 N. Kanayama, H. Shibata, A. Kimura, D. Miyamoto, T. Takarada
and M. Maeda, Biomacromolecules, 2009, 10, 805.
104 K. T. Wiss and P. Theato, J. Polym. Sci., Part A: Polym. Chem.,
2010, 48, 4758.
105 Z. F. Jia, J. Q. Liu, C. Boyer, T. P. Davis and V. Bulmus,
Biomacromolecules, 2009, 10, 3253.
106 Z. Jia, L.-J. Wong, T. P. Davis and V. Bulmus, Biomacromolecules,
2008, 9, 3106.
107 W. H. Liu, A. B. Greytak, J. Lee, J. Lee, C. R. Wong, J. Park,
L. F. Marshall, W. Jiang, P. N. Curtin, A. Y. Ting, D. G. Nocera,This journal is ª The Royal Society of Chemistry 2011D. Fukumura, R. K. Jain and M. G. Bawendi, J. Am. Chem. Soc.,
2010, 132, 472.
108 J. T. Lai, D. Filla and R. Shea, Macromolecules, 2002, 35, 6754.
109 C. W. Scales, Y. A. Vasilieva, A. J. Convertine, A. B. Lowe and
C. L. McCormick, Biomacromolecules, 2005, 6, 1846.
110 R. Wang, C. L. McCormick and A. B. Lowe,Macromolecules, 2005,
38, 9518.
111 Y. A. Vasilieva, D. B. Thomas, C. W. Scales and C. L. McCormick,
Macromolecules, 2004, 37, 2728.
112 A. Aqil, H. J. Qiu, J. F. Greisch, R. Jerome, E. De Pauw and
C. Jerome, Polymer, 2008, 49, 1145.
113 K. A. Aamer and G. N. Tew, J. Polym. Sci., Part A: Polym. Chem.,
2007, 45, 5618.
114 K. L. Heredia, T. H. Nguyen, C.-W. Chang, V. Bulmus, T. P. Davis
and H. D. Maynard, Chem. Commun., 2008, (28), 3245.
115 G. Chen, S. Amajjahe and M. H. Stenzel, Chem. Commun., 2009,
(10), 1198.
116 L. Zhang and Y. Chen, Polymer, 2006, 47, 5259.
117 D. L. Patton and R. C. Advincula, Macromolecules, 2006, 39, 8674.
118 D. Valade, C. Boyer, T. P. Davis and V. Bulmus, Aust. J. Chem.,
2009, 62, 1344.
119 L. M. Campos, K. L. Killops, R. Sakai, J. M. J. Paulusse,
D. Damiron, E. Drockenmuller, B. W. Messmore and
C. J. Hawker, Macromolecules, 2008, 41, 7063.
120 N. C. Strandwitz, A. Khan, S. W. Boettcher, A. A. Mikhailovsky,
C. J. Hawker, T.-Q. Nguyen and G. D. Stucky, J. Am. Chem.
Soc., 2008, 130, 8280.
121 R. Karunakaran and J. P. Kennedy, J. Polym. Sci., Part A: Polym.
Chem., 2008, 46, 4254.
122 E. Bays, L. Tao, C.-W. Chang and H. D. Maynard,
Biomacromolecules, 2009, 10, 1781.
123 S. N. S. Alconcel, G. N. Grover, N. M. Matsumoto and
H. D. Maynard, Aust. J. Chem., 2009, 62, 1496.
124 G. N. Grover, S. N. S. Alconcel, N. M. Matsumoto and
H. D. Maynard, Macromolecules, 2009, 42, 7657.
125 G. T. Hermanson, Bioconjugate Techniques, Academic Press, New
York, 1996.
126 D. Bontempo, K. L. Heredia, B. A. Fish and H. D. Maynard, J. Am.
Chem. Soc., 2004, 126, 15372.
127 K. L. Heredia, D. Bontempo, T. Ly, J. T. Byers, S. Halstenberg and
H. D. Maynard, J. Am. Chem. Soc., 2005, 127, 16955.
128 V. Bulmus, M. Woodward, L. Lin, N. Murthy, P. Stayton and
A. S. Hoffman, J. Controlled Release, 2003, 93, 105.
129 J. Liu, V. Bulmus, C. Barner-Kowollik, M. H. Stenzel and
T. P. Davis, Macromol. Rapid Commun., 2007, 28, 305.
130 H.M. Zareie, C. Boyer, V. Bulmus, E. Nateghi and T. P. Davis,ACS
Nano, 2008, 2, 757.
131 C. Boyer, J. Liu, L.-J. Wong,M. Tippett, V. Bulmus and T. P. Davis,
J. Polym. Sci., Part A: Polym. Chem., 2008, 46, 7207.
132 J. Liu, H. Liu, C. Boyer, V. Bulmus and T. P. Davis, J. Polym. Sci.,
Part A: Polym. Chem., 2009, 47, 899.
133 J. Liu, V. Bulmus, D. Herlambang, C. Barner-Kowollik,
M. H. Stenzel and T. P. Davis, Angew. Chem., Int. Ed., 2007, 46,
3099.
134 C. Boyer, J. Liu, V. Bulmus, T. P. Davis, C. Barner-Kowollik and
M. H. Stenzel, Macromolecules, 2008, 41, 5641.
135 K. Gunasekaran, T. H. Nguyen, H. Maynard, T. P. Davis and
V. Bulmus, Macromol. Rapid Commun., 2011, 32, 654.
136 H. Kakwere and S. Perrier, J. Am. Chem. Soc., 2009, 131, 1889.
137 V. Lima, X. Jiang, J. Brokken-Zijp, P. J. Schoenmakers,
B. Klumperman and R. Van Der Linde, J. Polym. Sci., Part A:
Polym. Chem., 2005, 43, 959.
138 M. Dietrich,M. Glassner, T. Gruendling, C. Schmid, J. Falkenhagen
and C. Barner-Kowollik, Polym. Chem., 2010, 1, 634.
139 B. S. Sumerlin and A. P. Vogt, Macromolecules, 2010, 43, 1.
140 M. Li, P. De, S. R. Gondi and B. S. Sumerlin, Macromol. Rapid
Commun., 2008, 29, 1172.
141 M. Teodorescu and K. Matyjaszewski, Macromol. Rapid Commun.,
1999, 32, 4826.
142 A. J. Convertine, B. S. Lokitz, Y. Vasileva, L. J. Myrick,
C. W. Scales, A. B. Lowe and C. L. McCormick, Macromolecules,
2006, 39, 1724.
143 G. G. Kochendoerfer, S. Y. Chen, F. Mao, S. Cressman,
S. Traviglia, H. Y. Shao, C. L. Hunter, D. W. Low, E. N. Cagle,
M. Carnevali, V. Gueriguian, P. J. Keogh, H. Porter,Polym. Chem., 2011, 2, 1463–1472 | 1471
Pu
bl
ish
ed
 o
n 
31
 M
ay
 2
01
1.
 D
ow
nl
oa
de
d 
on
 1
0/
03
/2
01
7 
10
:5
3:
07
. 
View Article OnlineS. M. Stratton, M. C. Wiedeke, J. Wilken, J. Tang, J. J. Levy,
L. P. Miranda, M. M. Crnogorac, S. Kalbag, P. Botti,
J. Schindler- Horvat, L. Savatski, J. W. Adamson, A. Kung,
S. B. H. Kent and J. A. Bradburne, Science, 2003, 299, 884.
144 C. Y. Hong and C.-Y. Pan, Macromolecules, 2006, 39, 3517.
145 A. F. Tominey, J. Liese, S. Wei, K. Kowski, T. Schrader and
A. Kraft, Beilstein J. Org. Chem., 2010, 6, 7.
146 J. Hentschel, M. G. J. ten Cate and H. G. Borner, Macromolecules,
2007, 40, 9224.
147 M. G. J. Ten Cate and H. G. Borner,Macromol. Chem. Phys., 2007,
208, 1437.
148 J. Hentschel, K. Bleek, O. Ernst, J. F. Lutz and H. G. Borner,
Macromolecules, 2008, 41, 1073.
149 Y. Zhao and S. Perrier, Chem. Commun., 2007, 4294.
150 P. De, M. Li, S. R. Gondi and B. S. Sumerlin, J. Am. Chem. Soc.,
2008, 130, 11288.1472 | Polym. Chem., 2011, 2, 1463–1472151 C. Boyer, V. Bulmus, J. Liu, T. P. Davis, M. H. Stenzel and
C. Barner-Kowollik, J. Am. Chem. Soc., 2007, 129, 7145.
152 H. Peng and H. Lin, Biomacromolecules, 2009, 10, 1804.
153 B. Apostolovic and H. A. Klok, Biomacromolecules, 2010, 11,
1891.
154 R. N. Johnson, R. S. Burke, A. J. Convertine, A. S. Hoffman,
P. S. Stayton and S. H. Pun, Biomacromolecules, 2010, 11,
3007.
155 H. Kitano, A. Hayashi, H. Takakura, H. Suzuki, N. Kanayama and
Y. Saruwatari, Langmuir, 2009, 25, 9361.
156 M. Hetzer, G. J. Chen, C. Barner-Kowollik and M. H. Stenzel,
Macromol. Biosci., 2010, 10, 119.
157 X. Z. Jiang, A. Housni, G. Gody, P. Boullanger, M. T. Charreyre,
T. Delair and R. Narain, Bioconjugate Chem., 2010, 21, 521.
158 F. Audouin, R. J. I. Knoop, J. Huang and A. Heise, J. Polym. Sci.,
Part A: Polym. Chem., 2010, 48, 4602.This journal is ª The Royal Society of Chemistry 2011
